HEMOSTASIS COAGULATION RESEARCH REAGENTS MONOCLONAL ANTIBODIES ANTI-PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 (PAI-1)
Mouse monoclonal antibody anti-human PAI-1, 5PAI, (IgG1)
Antigen : Reaction with active and latent PAI-1 and t-PA-PAI-1 complexes; no cross-reaction with PAI-2 or with PAI-3. Interferes with the functional activity of PAI-1.
Application : ELISA, immunodepletion, IHC
Host : Mouse
Informations
Plasminogen activator inhibitor 1 (PAI-1) is a glycoprotein, the primary inhibitor of t-PA and u-PA. It plays an essential role in controlling any excessive activation of fibrinolysis. It is present in plasma associated with vitronectin, in free form or associated with t-PA and in the alpha granules of platelets. Fibrinolysis corresponds to the solubilization of the fibrinous thrombus by plasmin, an enzyme originating from plasminogen adsorbed to fibrin. Plasminogen is activated by t-PA and u-Pa. PAI-1 by inhibiting plasminogen activators, controls the degradation of fibrinous thrombus. A decrease in fibrinolytic activity promotes the occurrence of thrombosis, while excessive fibrinolysis leads to hemorrhages.
Documentation
Download the product sheetPrice list, safety data sheets and notices are accessible to our registered customers.
References
4-TC21193 | Vial | 500 µg |